Standing squarely with his paws planted and his bright green eyes locked on the camera, the cat has the kind of confident posture that makes him look like he’s ready to guard the snack cabinet or ...

Recognizing the fine line between physical fitness and a compulsive need for size is becoming a critical first step toward ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 MDA Clinical and Scientific Conference, long-term data from its MESA ...

A little boy was diagnosed with a life-limiting, muscular condition after his parents realised he was unable to jump. Kairo ...

Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

Long-term data from DEVOTE/ONWARD studies show benefits of high dose nusinersen in people living with spinal muscular atrophy (SMA)New Phase 1b data further illustrate potential of salanersen in SMA, ...

The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...

Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD), announced at the MDA (Muscular Dystrophy ...

Cheri Gunvalson spoke in Washington on Tuesday, seeking FDA flexibility for ataluren, a drug vital to her son Jacob, who has Duchenne muscular dystrophy.

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...